Prognosis

Thai Premier Delays AstraZeneca Shot Over Probe Into Blood Clots

Temporary halt follows reports of blood clots after the shot
European regulators still back vaccine as review is underway

WATCH: Some data surrounding AstraZeneca’s shot “is a little head-scratching,” according to Johns Hopkins Virologist Andrew Pekosz.Source: Bloomberg)

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Randy Thanthong-Knight and Michelle Fay Cortez

March 12, 2021 at 1:47 AM UTC

Updated on

March 12, 2021 at 6:14 AM UTC

This article is for subscribers only.

Thailand joined Italy and a number of other European nations in temporarily suspending the use of AstraZeneca Plc’s Covid-19 vaccine pending an investigation into whether it may trigger blood clots.

The decision comes even as European regulators renewed their support of the immunization developed by Cambridge-based AstraZeneca and the University of Oxford, saying there was no indication the shot caused the clots that occur in thousands of people every year.